TIAA CREF Investment Management’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

TIAA CREF Investment Management’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-26,408	Closed	-$1.05K	–	3153
2016 Q3	$1.05K	Sell	26,408 -2,683	-9%	-$29.9K	﹤0.01%	2519
2016 Q2	$365K	Buy	29,091 +22,652	+352%	+$211K	﹤0.01%	2984
2016 Q1	$53K	Hold	6,439	–	–	﹤0.01%	3063
2015 Q4	$65K	Hold	6,439	–	–	﹤0.01%	3128
2015 Q3	$62K	Hold	6,439	–	–	﹤0.01%	3087
2015 Q2	$111K	Sell	6,439 -1,188	-16%	-$17.4K	﹤0.01%	3152
2015 Q1	$84K	Buy	7,627 +1,093	+17%	+$11.7K	﹤0.01%	3095
2014 Q4	$54K	Sell	6,534 -1,165	-15%	-$10K	﹤0.01%	3133
2014 Q3	$78K	Buy	7,699 +1,165	+18%	+$23K	﹤0.01%	3110
2014 Q2	$399K	Buy	+6,534	New	+$397K	﹤0.01%	3045

TIAA CREF Investment Management's TBRA Position: Q4 2016 in Review

TIAA CREF Investment Management sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 26,408 shares — an estimated $1.05K sold.

TIAA CREF Investment Management first reported a position in TBRA in Q2 2014 and held it in 10 quarters. The position peaked at $399K in Q2 2014. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

TIAA CREF Investment Management reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
TIAA CREF Investment Management sold 26,408 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $1.05K.
TIAA CREF Investment Management first reported a position in Tobira Therapeutics, Inc. Common Stock in Q2 2014 and held it in 10 quarters.
TIAA CREF Investment Management's Tobira Therapeutics, Inc. Common Stock position peaked at $399K in Q2 2014.
0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on TIAA CREF Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.